The Outcome of Neonatal Intensive Care


Technical advances and aggressive improvements in perinatal care have been primarily responsible for the improved survival of high-risk neonates ( Fig. 19.1 , Tables 19.1 and 19.2 ) Despite marked improvements in survival, there has been minimal progress in decreasing morbidities. A major concern persists that neonatal intensive care can result in an increase in the number of permanently handicapped children. Because perinatal interventions can impact later growth and development, long-term follow-up is essential to ensure that newer therapies that demonstrate dramatic and immediate positive effects are not associated with adverse long-term outcomes. In recognition of the importance of these long-term outcomes, many modern prospective randomized interventional trials have extended their primary outcome to school age, with the goal being absence of harm and normal long-term neurodevelopment.

(Younge N, Goldstein RF, Bann CM, et al. Survival and neurodevelopmental outcomes among periviable infants. N Engl J Med. 2017;376:617-628.)
Editorial Comment:

Although there has been tremendous progress in neonatology over the last century, there has also been a history of errors in neonatology and babies who were injured when given therapies designed to help them. It is for this reason that one of the forefathers of neonatology, Bill Silverman, exhorted clinicians to “teach thy tongue to say I do not know and thou shalt progress.” At the same time, it must be acknowledged how difficult it is for researchers to design trials with questions that will only be answered 10 years later. Additionally, as noted above, over a period of a decade, there has only been a 4% increase in survival without any neurodevelopmental impairment in babies born between 23 and 25 weeks’ gestation.

Fig. 19.1
Trends in Survival. Improvement in survival of low-birth-weight infants. Note that the figure stops in 2003 because of the fact that more recent outcomes research has focused more on gestational age as opposed to weight. NICHD, National Institute of Child Health and Human Development; OTA, Office of Technology Assessment.

Data for 1966 to 1985 from U.S. Congress, Office of Technology Assessment (OTA): Neonatal Intensive Care for Low-Birthweight Infants: Cost and Effectiveness . Health Technology Case Study 38. Washington, DC: U.S. Congress; 1987; data for 1992, 1999, and 2003 from Stevenson DK, Wright LL, Lemons JA, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol 1998;179:1632; Fanaroff AA, Stoll BJ, Wright LL, et al; NICHD Neonatal Research Network: Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007;196[2]:147, e1; data for 1997 from Rainbow Babies and Children’s Hospital, Cleveland, Ohio.

TABLE 19.1
Survival and Neurodevelopmental Impairment According to Gestational Age
Modified from Tyson JE, Parikh NA, Langer J, et al for the National Institute of Child Health and Human Development Neonatal Research Network. Intensive care for extreme prematurity—moving beyond gestational age. N Engl J Med 2008;358:1672.
Gestational Age (wk) Survival (%) NDI (%) Survival Without NDI (%)
22 5 80 1
23 26 65 9
24 56 50 28
25 76 39 46
NDI , Neurodevelopmental impairment.

TABLE 19.2
Outcome Variables at 23 to 25 Months’ Corrected Age
Modified from Pierrat V, Marchand-Martin L, Arnaud C, et al. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks’ gestation in France in 2011: EPIPAGE-2 cohort study. BMJ . 2017;358:j3448.
24–26 Weeks 27–31 Weeks 32–34 Weeks
Total followed ( n ) 450 2264 885
Cerebral palsy 7% 4% 1%
Deafness 1% 0.6% 0.5%
Blindness 0.7% 0.3% 1%
Subnormal development a 50% 41% 36%
Moderate/severe neuromotor or sensory disability b 6% 3% 1%

a Ages and Stages Questionnaire score <2 standard deviations below mean

b Cerebral palsy with Gross Motor Function Classification System (GMFCS) level 3–5 and /or bilateral deafness and or bilateral blindness

The initial follow-up studies of preterm infants in the early 1970s described a decrease in unfavorable neurodevelopmental sequelae compared with the era before neonatal intensive care. Despite the continued decrease in mortality rates, the incidence of neurosensory and developmental handicaps initially remained constant in the 1980s; however, morbidity increased in the 1990s following a further decrease in mortality, which was associated with antenatal steroid and surfactant therapies introduced in the early 1990s. These treatments resulted in the survival of high-risk infants who previously would have died. Furthermore, postnatal steroid therapy, which was widely used to prevent or treat bronchopulmonary dysplasia, resulted in higher rates of cerebral palsy (CP). The absolute number of both healthy and neurologically impaired children in the population thus increased in the 1990s. Additional morbidity resulted from increased infection, necrotizing enterocolitis, and poor physical growth in infants of extremely low birth weight (<1 kg) and short gestation (<26 weeks).

Since 2000, the outcomes of children with a birth weight of less than 1 kg have improved; this improvement has resulted from a significant decrease in nosocomial infections and intraventricular hemorrhage, together with a decrease in the use of postnatal steroid therapy.

When outcome results are evaluated, considerable variation is noted in the results cited in different reports. One reason is that selection of patients by birth weight does not guarantee a homogeneous group, and populations studied in one center may differ considerably from those studied in another center. There are several causes for these differences. One of the most important factors is the pattern of referral to the neonatal intensive care unit (NICU). Units that receive admissions from numerous outlying hospitals have a selected population that may contain a disproportionate number of the sickest babies or may include only those infants deemed well enough to transport. In addition, patients treated in an “inborn” unit have the advantage of consistent and, presumably, good obstetric care coupled with the opportunity for immediate postnatal resuscitation and management. Inadequate resuscitation at birth and prolonged hypoxia and acidemia, together with the cold stress associated with transport that may be seen in referred patients, influence not only the outcome in the period immediately after birth but also the type and frequency of developmental sequelae. Other factors that may influence outcome include (1) the socioeconomic profile of the parents, (2) the proportion of infants with intrauterine growth restriction, (3) the incidence of extreme prematurity, (4) a selective admission policy, (5) a selective treatment policy, and (6) changes in therapy during the study period.

The major clinical outcomes that are important to preterm infants and their families are not only survival, but survival accompanied by normal long-term neurodevelopment. These goals are not easily attainable; however, the landscape has improved over the past two decades, and there are now more intact survivors who attend mainstream schools and ultimately live independently. How to preserve brain function and permit normal brain development ex utero remain enormous challenges. The period between 20 and 32 weeks after conception is one of rapid brain growth and development. Illness, hemorrhage, ischemia, and metabolic disturbances such as hypoglycemia, hyperbilirubinemia, undernutrition, and infection during this time may compromise neurodevelopment. Indeed, events leading to the premature birth such as chorioamnionitis may have stimulated the release of cytokines that in turn injure the developing brain. Scores of publications continue to demonstrate a myriad of cognitive (mental), behavioral, and functional problems in the most immature babies compared with their term peers.

Editorial Comment:

Follow-up of graduates from the intensive care unit has shed the orphan role it had for so long, and outpatient neonatology clinics are now a genuine and legitimate component of neonatology. Minimizing harm and maximizing the opportunity for long-term neurodevelopment are the desired outcome.

Measures of outcomes of neonatal care include the rate of mortality before and after discharge from the neonatal intensive care nursery, rate of rehospitalizations, and incidence of chronic medical conditions such as asthma and growth failure.

According to the Centers for Disease Control and Prevention (CDC), the mortality rate for US preterm infants was 3.46% in 2013, a survival rate of more than 96%. In 2016, the CDC reported a 9.8% prematurity rate up from 9.6% in 2015.

Survival is proportional to the gestational age, and there is marked variability in outcome and interventions by country and even within countries. The survival at 22 weeks’ gestational age ranges from 40% in Japan, 20% in Sweden, to less than 5% in parts of Europe where no effort is made to care for infants at this gestational age. About 40% of infants will survive at 23 weeks’ gestation, but even though approximately 70% of infants survive at 24 weeks’ gestation, few survive without major morbidity defined as one or more of necrotizing enterocolitis, infection, bronchopulmonary dysplasia, severe periventricular haemorrhage, periventricular leukomalacia, or retinopathy of prematurity stage 3 or greater.

At 25 weeks and 26 weeks, 81% and 87% of infants survive, respectively, with approximately one-fifth who do so free of major morbidity. From 27 weeks on, survival is 94%, and half of them survive free of major morbidity. Observing the long-term follow-up of these infants is essential, and the impression is that long-term neurodevelopmental outcome is improving for at least some gestational age groups. Norman’s data from Sweden including 1196 extremely preterm infants, revealed that 1-year survival among live-born infants increased from 70% during 2004 to 2007 to 77% during 2014 to 2016, and survival without any major morbidity increased from 32% to 38%, respectively.

Neurodevelopmental sequelae include subnormal and borderline cognitive function and neurosensory deficits such as CP, deafness, and blindness. These sequelae have traditionally been used as outcome measures. Other outcomes include functional abilities and the ability to perform the activities of daily living. Additional measures involve special healthcare requirements such as the need for technologic aids, frequent physician visits and medications for chronic conditions, occupational and physical therapy, and special education and counseling. Other measures may include impact on the family, quality of life, and cost of care.

Editorial Comment:

Preterm subjects, even excluding those with severe disabilities, compared with term controls, are at increased risk of exhibiting problems related to executive dysfunction. Among adolescents born preterm, severe brain injury on neonatal ultrasound and lower maternal education are the most consistent factors associated with poor outcomes and problems with executive function.

Regional outcome studies provide the most accurate data because they include all infants born in a region rather than hospital-based results. Such studies have rarely been undertaken in the United States, although they have been performed in Canada, the United Kingdom, and Australia. Results may also be reported from multigroup studies or randomized controlled trials of various therapies ( Box 19.1 ).

(Smith LK, Morisaki N, Morken N, et al. An international comparison of death classification at 22 to 25 weeks’ gestational age. Pediatrics. 2018;142[1]:e20173324.)
Editorial Comment:

International studies are helpful but must be interpreted with caution. A study examining neonatal survival rates among several countries found that the variation in survival rates at 22 to 23 weeks’ gestation decreased significantly when stillbirths were added to the denominator. Data may be collected, interpreted, and analyzed differently in different parts of the world.

BOX 19.1
Measures of Very Low-Birth-Weight Outcome

  • Survival

    • To discharge

    • After discharge

  • Medical morbidity

    • Rehospitalization

    • Chronic lung disease

    • Growth failure

  • Neurodevelopmental outcome

    • Motor dysfunction (cerebral palsy)

    • Mental retardation

    • Seizures

    • Vision problems

    • Hearing disorders

    • Behavioral problems

    • School-age outcomes

  • Functional outcomes

    • Health or illness

    • Activity and skills of daily living

    • Ambulation

    • Need for technologic aids (gastric tube, oxygen)

    • Need for special services

  • Quality of life

  • Impact on family

  • Cost of care

The risk of neurodevelopmental problems increases as birth weight and gestational age decrease. Additional risk factors include the occurrence of neonatal seizures; severe periventricular hemorrhage ; periventricular leukomalacia ; bronchopulmonary dysplasia, defined as an oxygen requirement at 36 weeks’ postconceptional age; and severe intrauterine or neonatal growth failure, specifically a subnormal head circumference (≤2 standard deviations [SDs] from the mean) at discharge. Children born to mothers who have a low educational level or live in poverty demonstrate the additional detrimental effects of the environment. Among term-born children, risk factors for later neurologic and developmental sequelae also include perinatal asphyxia, neonatal seizures, an abnormal neurologic finding at discharge, and persistent pulmonary hypertension requiring prolonged ventilator therapy, nitric oxide therapy, or extracorporeal membrane oxygenation. Children born with multiple major malformations also constitute a group that generally has a poor developmental outcome ( Box 19.2 ). Over the past decade, evidence has emerged that children who experience critical illness in the newborn period, regardless of the underlying diagnosis, are at risk for memory impairment and academic problems, even with normal intelligence.

BOX 19.2
Factors Affecting Outcomes for the Very Low-Birth-Weight Infant

  • Birth weight <750 g or <26 weeks’ gestation

  • Periventricular hemorrhage (grade III or IV)

  • Periventricular leukomalacia or other echodense lesions

  • Persistent ventricular dilatation

  • Neonatal seizures

  • Chronic lung disease

  • Neonatal meningitis

  • Subnormal head circumference

  • Poverty or parental deprivation

  • Congenital malformations

  • Outborn status (born at a center without a tertiary care neonatal intensive care unit)

Importance of Follow-Up for High-Risk Infants

Follow-up clinics should be an integral part of every NICU. Specialized care for problems of growth, sequelae of bronchopulmonary dysplasia, and adaptation is best provided within the setting of a neonatal follow-up program. This care should initially be provided by the neonatal department and then gradually transferred to developmental and educational specialists. The initial continuity of care is important to the family, who will find reassurance in the fact that the same people who were responsible for the life-saving decisions early in the infant’s life are continuing to assume responsibility for the child’s adaptation into home life. There is also a moral obligation to maintain this contact. Furthermore, even if the neonatologist does not continue the follow-up for an extended period, he or she will benefit greatly by maintaining contact with the nursery graduates and recognizing the sequelae of the early neonatal interventions.

When growth and neurodevelopmental outcomes are assessed, it is important to correct the child’s age to account for the preterm birth. This should be done at least until the child is 3 years of age. For extremely immature infants (i.e., those born at 23–25 weeks’ gestation), such age correction may be necessary until at least 5 years of age. Although the concept of correction for prematurity is most important during the early childhood years, evidence suggests that this correction continues well into school age, as standardized test scores for cognition and development continue to show improvement throughout school years.

Minor Transient Problems

The first few months after the neonate’s discharge can be considered a period of convalescence for the infant and parents as well. Many infants have minor problems specifically related to being born preterm, but these may be seen as major problems to their parents. These problems include anemia of prematurity, umbilical and inguinal hernias, relatively large, dolichocephalic, “preemie-shaped” heads, and subtle behavioral differences. Most healthy preterm infants are discharged home at 36 to 37 weeks’ gestational age (or when they weigh about 1.9 kg). At this age, they still tend to sleep most of the day, waking only for feedings; to feed slowly and not always to demonstrate hunger; to sometimes be jittery; and to have “preemie” vocalizations, which include grunts and a relatively high-pitched cry. It is important to introduce parents of children recovering from neonatal illness to the concept of developmental milestones, as these children have often been secluded from contact with other children and developmentally restricted by medical issues.

Transient Neurologic Abnormality

There is a very high incidence of transient neurologic abnormality during the first year of life, ranging from 20% to 40% among preterm infants, with a peak incidence of transient dystonia occurring at 7 months’ corrected age. These include abnormalities of muscle tone such as hypotonia or hypertonia. Such abnormalities present as poor head control at 40 weeks’ corrected age (the expected term date), poor back support at 4 to 8 months, and sometimes a slight increase in the tone of the upper extremities. Because there is normally some degree of hypertonia during the first 3 months after term, it is difficult to diagnose the early developing spasticity related to CP. Children in whom CP later develops show hypotonia (poor head control and back support) initially and only later manifest spasticity of the extremities combined with truncal hypotonia. Spasticity during the first 3 to 4 months of life is an indicator of poor prognosis. Mild hypertonia or hypotonia persisting at 8 months usually resolves by the second year of life. Persistence of primitive reflexes beyond 4 months’ corrected age might be a sign of early CP. Major neurologic handicap presents during the first 6 to 8 months after term in about 10% of newborns in the most high-risk categories; however, 90% of high-risk newborns will be or become neurologically normal after the first year of life. Although most cases of mild hypotonia or hypertonia detected at 8 months usually resolve, they may indicate later subtle neurologic dysfunction.

Persistent Neurologic Sequelae

Major neurologic handicap can usually be defined during the latter part of the first year of life or even earlier if severe. It is usually classified as CP (spastic diplegia, spastic quadriplegia, or spastic hemiplegia or paresis), hydrocephalus (with or without accompanying CP or sensory deficits), blindness (usually caused by retinopathy of prematurity), or deafness. Blindness currently occurs very rarely because laser treatment or cryotherapy for severe retinopathy of prematurity may prevent the progression of this disease. CP is an umbrella term encompassing a group of nonprogressive, noncontagious motor conditions that cause physical disability in human development, chiefly in the various areas of body movement. The neurologic symptoms of spastic CP include increased tone with velocity-dependent increased resistance to passive movement, pathologic reflexes such as hyperreflexia or pyramidal signs like the Babinski response, and abnormal patterns of movement and posture characterized in the lower limbs by equines foot, crouch gait, internal rotation, and hip adduction. In the upper limbs, the typical posture is arm flexion with fisted hands, adducted thumbs, and poorly coordinated finger movements. Symptoms of bilateral spastic CP include motor deficit with contractures, impaired normal gait, cognitive problems (seen less often in preterm than term children), visual problems such as blindness or strabismus, and epilepsy in the most severe cases. Although the vast majority of affected children have spastic CP, extrapyramidal forms, such as ataxic, dystonic, or dyskinetic CP, are increasing and may present with poor coordination, global hypotonia, or abnormal movements.

(Shepherd E. Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2017;8:CD012.)
Editorial Comment:

Most healthcare providers are familiar with the relatively high risk of cerebral palsy in preterm infants. Nonetheless, as the vast majority of births are at term, numerically it is term and late preterm infants who account for the majority of cases of cerebral palsy despite their significantly lower risk. In an extensive review on cerebral palsy, Shepherd found that magnesium sulfate for women at risk of preterm birth for fetal neuroprotection can prevent cerebral palsy. Also, prophylactic antibiotics for women in preterm labor with intact membranes, and immediate rather than deferred birth of preterm babies with suspected fetal compromise, may increase the risk of cerebral palsy.

Because CP is a central motor disorder with an incidence that is inversely related to gestational age, it is often used as a marker of neonatal outcome. The developmental and intellectual outcomes differ according to the severity of CP. For example, children with spastic quadriplegia usually have severe intellectual disability, whereas children with spastic diplegia or hemiplegia may have relatively intact mental functioning. Mental functioning is not always measurable in these children until after 2 to 3 years of age. In recognition of the fact that the severity of CP greatly affects the functional outcomes, there has been increased emphasis on functional assessments such as the Gross Motor Function Classification System, which defines motor function according to self-initiated movement with emphasis on sitting, walking, and mobility using a five-level classification system in which criteria meaningful to daily living distinguish the levels.

Isolated motor disorders, such as developmental coordination disorder, which affects approximately one-third of preterm children, are more common than CP. By definition, these children have no neurosensory impairment and demonstrate intact cognitive function. They display a variety of fine and gross motor delays resulting in difficulties with common motor tasks such as manipulating pencils or silverware, pedaling a bicycle, or performing routine motor tasks of daily living.

Physical Sequelae and Chronic Disease

A variety of common problems of prematurity often continue after NICU discharge. Anemia of prematurity is common, necessitating the monitoring of hemoglobin levels and reticulocyte counts, which typically rise by 3 to 6 months. Apnea of prematurity, resulting from immature regulation of breathing, may recur in infants who develop upper respiratory infections or require anesthesia for surgical procedures such as inguinal hernia repair.

Chronic diseases of prematurity, mainly chronic lung disease (bronchopulmonary dysplasia), gradually resolve during infancy, although children with bronchopulmonary dysplasia have higher rates of recurrent respiratory infections and asthma during childhood. Some may require weaning from home oxygen or withdrawal of discharge medications such as diuretics or bronchodilators. Scars from various neonatal surgical procedures (tracheotomy, thoracocentesis, Broviac lines, shunt procedures) tend to fade gradually and appear less significant as the child grows. There is, however, a high rate of rehospitalization, especially for those children of extremely low birth weight who have bronchopulmonary dysplasia or neurologic sequelae. Fifty percent of children with chronic lung disease may be hospitalized in the first year after discharge. Many hospitalizations that occur in winter have been because of respiratory syncytial virus infections. These may be minimized with respiratory syncytial virus immunization. Children with neurologic sequelae such as CP or hydrocephalus also have a higher rate of rehospitalization for shunt complications, orthopedic correction of spasticity, and eye surgery for strabismus.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here